| Metric | FY2019 | FY2018 | FY2017 |
|---|---|---|---|
| Sales | $785.4M+10.2% | $713.0M+12.1% | $636.0M |
| Cost of goods sold | $180.0M+12.9% | $159.4M+6.0% | $150.5M |
| Gross profit | $605.4M+9.4% | $553.6M+14.0% | $485.5M |
| Research and development | $60.1M+8.2% | $55.5M+27.1% | $43.7M |
| Selling, general and administrative | $354.8M+13.9% | $311.6M+16.3% | $267.8M |
| Amortization of intangibles | $13.8M+44.0% | $9.6M+21.2% | $7.9M |
| Acquisition related costs | $2.6M+53.2% | $1.7M+4.3% | $1.6M |
| Total operating expenses | $433.4M+12.8% | $384.2M+18.7% | $323.7M |
| Operating income | $172.0M+1.6% | $169.3M+4.6% | $161.8M |
| Interest income/(expense), net | $17.4M+31.1% | $13.3M+100.9% | $6.6M |
| Foreign currency transaction gain/(loss) | $75K-79.2% | $360K-60.4% | $909K |
| Other income/(expense) | $476K-91.6% | $5.6M+888.1% | $571K |
| Total other income/(expense), net | $18.0M-6.9% | $19.3M+138.4% | $8.1M |
| Income before income taxes | $189.9M+0.7% | $188.6M+11.0% | $169.9M |
| Income tax provision | $34.7M+8.1% | $32.1M-48.7% | $62.6M |
| Net income | $155.2M-0.8% | $156.5M+45.8% | $107.3M |
| Basic | $99.2M+1.3% | $97.9M+1.7% | $96.2M |
| Diluted | $102.0M+0.7% | $101.3M+3.5% | $97.9M |
| Dilutive stock options | $2.8M-17.0% | $3.4M+108.8% | $1.6M |
| Anti-dilutive stock options excluded from weighted average calculation | $4.5M+83.4% | $2.5M-14.7% | $2.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.